CARGO Therapeutics (CRGX) Competitors $4.37 -0.20 (-4.38%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$4.38 +0.00 (+0.11%) As of 05/1/2025 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRGX vs. NTLA, SYRE, ZYME, RCUS, NRIX, CMRX, CDMO, ELVN, OCS, and GYREShould you be buying CARGO Therapeutics stock or one of its competitors? The main competitors of CARGO Therapeutics include Intellia Therapeutics (NTLA), Spyre Therapeutics (SYRE), Zymeworks (ZYME), Arcus Biosciences (RCUS), Nurix Therapeutics (NRIX), Chimerix (CMRX), Avid Bioservices (CDMO), Enliven Therapeutics (ELVN), Oculis (OCS), and Gyre Therapeutics (GYRE). These companies are all part of the "pharmaceutical products" industry. CARGO Therapeutics vs. Intellia Therapeutics Spyre Therapeutics Zymeworks Arcus Biosciences Nurix Therapeutics Chimerix Avid Bioservices Enliven Therapeutics Oculis Gyre Therapeutics Intellia Therapeutics (NASDAQ:NTLA) and CARGO Therapeutics (NASDAQ:CRGX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation. Is NTLA or CRGX more profitable? CARGO Therapeutics' return on equity of -38.16% beat Intellia Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Intellia TherapeuticsN/A -49.34% -40.27% CARGO Therapeutics N/A -38.16%-33.94% Does the MarketBeat Community prefer NTLA or CRGX? Intellia Therapeutics received 430 more outperform votes than CARGO Therapeutics when rated by MarketBeat users. Likewise, 68.94% of users gave Intellia Therapeutics an outperform vote while only 66.67% of users gave CARGO Therapeutics an outperform vote. CompanyUnderperformOutperformIntellia TherapeuticsOutperform Votes44468.94% Underperform Votes20031.06% CARGO TherapeuticsOutperform Votes1466.67% Underperform Votes733.33% Which has more risk and volatility, NTLA or CRGX? Intellia Therapeutics has a beta of 2.23, indicating that its stock price is 123% more volatile than the S&P 500. Comparatively, CARGO Therapeutics has a beta of 0.66, indicating that its stock price is 34% less volatile than the S&P 500. Do analysts rate NTLA or CRGX? Intellia Therapeutics currently has a consensus target price of $36.68, suggesting a potential upside of 324.59%. CARGO Therapeutics has a consensus target price of $15.00, suggesting a potential upside of 243.25%. Given Intellia Therapeutics' stronger consensus rating and higher possible upside, research analysts clearly believe Intellia Therapeutics is more favorable than CARGO Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intellia Therapeutics 1 Sell rating(s) 6 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.65CARGO Therapeutics 1 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86 Which has better valuation and earnings, NTLA or CRGX? CARGO Therapeutics has lower revenue, but higher earnings than Intellia Therapeutics. Intellia Therapeutics is trading at a lower price-to-earnings ratio than CARGO Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIntellia Therapeutics$57.88M15.45-$481.19M-$5.25-1.65CARGO TherapeuticsN/AN/A-$98.15M-$3.72-1.17 Do institutionals and insiders believe in NTLA or CRGX? 88.8% of Intellia Therapeutics shares are held by institutional investors. Comparatively, 93.2% of CARGO Therapeutics shares are held by institutional investors. 3.2% of Intellia Therapeutics shares are held by insiders. Comparatively, 1.4% of CARGO Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media favor NTLA or CRGX? In the previous week, Intellia Therapeutics had 15 more articles in the media than CARGO Therapeutics. MarketBeat recorded 16 mentions for Intellia Therapeutics and 1 mentions for CARGO Therapeutics. CARGO Therapeutics' average media sentiment score of 1.71 beat Intellia Therapeutics' score of 1.23 indicating that CARGO Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Intellia Therapeutics Positive CARGO Therapeutics Very Positive SummaryIntellia Therapeutics beats CARGO Therapeutics on 10 of the 17 factors compared between the two stocks. Get CARGO Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRGX vs. The Competition Export to ExcelMetricCARGO TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$201.25M$2.95B$5.53B$7.93BDividend YieldN/A1.89%5.11%4.22%P/E Ratio-1.0330.0722.5918.54Price / SalesN/A494.82401.35103.29Price / CashN/A168.6838.1834.62Price / Book0.443.176.774.25Net Income-$98.15M-$72.35M$3.22B$248.18M7 Day Performance-3.10%2.14%1.39%1.03%1 Month Performance3.31%5.67%2.78%2.70%1 Year Performance-79.15%-23.57%15.85%4.05% CARGO Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRGXCARGO Therapeutics2.0849 of 5 stars$4.37-4.4%$15.00+243.2%-78.7%$201.25MN/A-1.03116News CoveragePositive NewsNTLAIntellia Therapeutics4.6688 of 5 stars$7.92+9.5%$36.68+363.2%-61.6%$819.86M$57.88M-1.46600Upcoming EarningsHigh Trading VolumeSYRESpyre Therapeutics1.911 of 5 stars$13.57+7.1%$49.57+265.3%-56.7%$817.95M$890,000.00-1.82100Upcoming EarningsNews CoveragePositive NewsZYMEZymeworks2.7612 of 5 stars$11.75+1.9%$21.00+78.7%+47.0%$817.53M$76.30M-7.83460Upcoming EarningsAnalyst RevisionNews CoveragePositive NewsRCUSArcus Biosciences2.2724 of 5 stars$7.68-2.5%$30.25+293.9%-44.4%$807.46M$258M-2.44500Upcoming EarningsNews CoveragePositive NewsGap DownNRIXNurix Therapeutics1.9233 of 5 stars$10.55+3.0%$30.44+188.6%-14.7%$804.29M$56.42M-3.65300Analyst ForecastCMRXChimerix2.998 of 5 stars$8.55-0.1%$8.53-0.1%N/A$801.56M$212,000.00-9.0990CDMOAvid Bioservices0.7329 of 5 stars$12.50+0.1%$12.25-2.0%+62.9%$799.18M$139.91M-5.23320High Trading VolumeELVNEnliven Therapeutics2.2518 of 5 stars$16.22-1.9%$40.33+148.7%+9.7%$794.85MN/A-8.5450News CoveragePositive NewsGap DownOCSOculis2.8636 of 5 stars$18.12-0.8%$30.25+66.9%+38.0%$791.16M$980,000.00-9.392Positive NewsGYREGyre Therapeutics0.0652 of 5 stars$8.40-5.4%N/A-32.6%$786.34M$105.76M168.0040Upcoming EarningsNews Coverage Related Companies and Tools Related Companies NTLA Competitors SYRE Competitors ZYME Competitors RCUS Competitors NRIX Competitors CMRX Competitors CDMO Competitors ELVN Competitors OCS Competitors GYRE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRGX) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CARGO Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CARGO Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
